See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Stoneridge, Inc. (SRI) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stoneridge, Inc. (SRI) - free report >>
Image: Bigstock
New Strong Buy Stocks for December 29th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Stoneridge, Inc. (SRI - Free Report) : This designer and manufacturer of engineered electrical and electronic components has seen the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.
Stoneridge, Inc. Price and Consensus
Stoneridge, Inc. price-consensus-chart | Stoneridge, Inc. Quote
Eni SpA (E - Free Report) : This company engaged in the exploration, development and production of hydrocarbons has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
ENI S.p.A. Price and Consensus
ENI S.p.A. price-consensus-chart | ENI S.p.A. Quote
Medpace Holdings Inc (MEDP - Free Report) : This clinical contract research organization has seen the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.
Medpace Holdings, Inc. Price and Consensus
Medpace Holdings, Inc. price-consensus-chart | Medpace Holdings, Inc. Quote
Sucampo Pharmaceuticals, Inc. : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Sucampo Pharmaceuticals, Inc. Price and Consensus
Sucampo Pharmaceuticals, Inc. price-consensus-chart | Sucampo Pharmaceuticals, Inc. Quote
Woori Bank Co., Ltd. (WF - Free Report) : This company that provides commercial banking products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.Woori Bank Price and Consensus
Woori Bank price-consensus-chart | Woori Bank Quote
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>